Next generation sequencing combined with functional metagenomic analysis and genetic engineering have the potential to expedite the development of enzymes for the control of mycotoxins at a feed level, says academic.
A new dileucine ingredient that leads to over 40% more muscle building potential than leucine alone is being commercialized by start-up Ingenious Ingredients, with the company already “vetting exclusive top-tier distribution and marketing partners”.